For press inquiries click here to contact us.
Element Biosciences
Element Biosciences unveils Aviti benchtop sequencing system
Evonetix
Evonetix Developing Thermally Controlled Enzymatic DNA Synthesis
DNAnexus, Inc.
DNAnexus Raises $200M Financing, with Platform Expansion in Mind
Cue Health
How Cue Health’s Covid-19 Test Became the Go-To for Business
Element Biosciences Partners With Informatics Experts Sentieon and Google DeepVariant to Validate the AVITI™ System’s NGS Data Quality for Variant Calling
Element Biosciences
Element Biosciences acquires Loop Genomics to add long-read tech to DNA sequencing platform
Alumis, Inc.
Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis
Detect, Inc.
As Omicron Spreads, New PCR-Like At-Home Covid Tests Provide Fast, Accurate Results
ImmPACT Bio, Inc.
Novartis-backed ImmPACT Bio snags $111M and new CEO as cancer CAR-T yields phase 1 results
Please see important disclaimers in the Terms section.
